+ND Capital

3B Future Health Ventures

AAA Family Office

AATec Medical GmbH

Abalos Therapeutics GmbH

abcDNA GmbH

ABG Sundal Collier

ADOCIA

AFK & Partners Asset Management LLC

AK Pharma Consulting

Akasi Pharma ApS

Akribion Therapeutics GmbH

Algiax Pharmaceuticals GmbH

Alkapharmics SARL

Allogenetics GmbH

Alondras Therapeutics

AM-Pharma B.V.

Ampleia

Amporin Pharmaceuticals AG

AMR Action Fund GP GmbH

Anavo Therapeutics BV

Andera Partners SA

Angelini Ventures S.p.A.

AnRes Clinical

Antabio SAS

Aphaia Pharma AG

ARCHIMED

Arcinova

Arkadian VC

ARTCLINE GmbH

Asahi Kasei Europe GmbH

Ascension Ventures

Asian Innovation & Finance Center (AIFC)

Asklepios Advisors

AstraZeneca

Aukera Therapeutics GmbH

AurorA Science Srl

AVEROA SAS

Awen GmbH

Basel Area Business & Innovation

BaseLaunch

Bayer Consumer Care AG

Bergmann zur Hausen & Cie. GmbH

Berlin Partner für Wirtschaft und Technologie GmbH

BERNINA BioInvest Ltd.

Biocytogen

BioGeneration Ventures (BGV)

BioMedPartners AG

BiomedVC AG

BioPartner UK

BioPharma Drug Licensing Group SL

Bioqube Ventures

BIOSTART Consulting GmbH

BioTalent

biotx.ai GmbH

Biovision Ventures

BioXconomy

Bioxodes SA

BiPER Therapeutics

Bird & Bird (Belgium) LLP

BlackRock

Bloomberg L.P.

Boehler Life Science Advice

Boehringer Ingelheim International GmbH

Bootstrap Europe

Breslin AG

Brutkasten GmbH / VentureCapital Magazin

Business Angels Switzerland

Cancer Research Horizons

Capital Grand Est

Cbio A/S

CDR-Life AG

Claris Ventures SGR SpA

ClavystBio

Clinilabs, LLC

CMS Medical Venture Investment Ltd.

Cohesion Bureau

Coho VC

Convergence Partners

Corinthian financial management Ltd

Coulter Partners

CPTx GmbH

Cube Labs SpA

Cukierman & Co. Investment House Ltd.

Cukierman & Co. Life Sciences

Curie.Bio

Curlim

DeBere Capital Partners

Delin Ventures

DelSiTech Ltd.

Dementia Discovery Fund, an SV Health Investors, LLC Fund

Digital Networks PLC

Dimericon Therapeutics AG

docdok.health AG

DOLINNOV

École polytechnique fédérale de Lausanne (EPFL)

Elaia Partners

ELARIS FlexCo

eleva GmbH

Eli Lilly and Company

Engager BIO BV

Epidarex Capital

EpimAb Biotherapeutics

Epitome Therapeutics FlexCo

EQT Life Sciences

Ervimmune

ESC Advisors

European Investment Bank

Evernow Publishing Ltd, publisher of MedNous

Evox Therapeutics Ltd.

ExpreS2ion Biotech Holding AB

F. Hoffmann-La Roche

Fapon Biopharma

FatiAbGen International GmbH

FCF Fox Corporate Finance GmbH

Flagship Pioneering

Flerie Invest AB

Forbion

Fortlane Partners GmbH

Forty51 Ventures AG

FreeMind Group

Futurewave AG

Galileo Research Srl

Galimedix Therapeutics, Inc.

Genius Search GmbH & Co. KG

GHF - Golden Heart Flower Ltd.

GIBF

Gilde Healthcare Partners BV

Gimv

Global Life Science Ventures GmbH

Gold Nest Capital

Granite Bio

GSK

Hadean Ventures

HeartBeat.bio AG

Hemastatx GmbH

hemotune AG

HEPHAISTOS-Pharma

Hevolution

High-Tech Gründerfonds Management GmbH

Hippocrates Research S.A

Hong Kong Exchanges and Clearing Limited (HKEX)

Hong Kong Trade Development Council

ICF Consult Switzerland

Igyxos

Innovestor Life Science Ltd.

Intelligencia AI

Intragel Therapeutics Ltd.

InvestHK

invIOs GmbH

IODAX Pharma AG

iOmx Therapeutics AG

IPF Partners

IQ Capital

ITM Isotope Technologies Munich SE

J.P. Morgan

J.P. Morgan Switzerland

Jeito Capital

JFG Life Sciences Stiftung der Universität Basel

KBI Biopharma, Inc.

Kerna Ventures

kez.biosolutions GmbH

KHAN Technology Transfer Fund

Khondrion BV

Kurma Partners

Landmark BioVentures AG

Laverock Therapeutics Ltd.

Leads To Development

Lexogen GmbH

Limani Partners

LimmaTech Biologics AG

Limula

LINK Medical

LMU Munich

LongeVC

Lonza AG

Lumina Life Sciences

Lytix Biopharma AS

M&G Advisors GmbH

M2care Venture Studio

Macomics Ltd.

MC Services AG

Meddenovo Drug Design SAS

Medicines Discovery Ventures

Medicxi

MEDiSTRAVA

Meliodays Medical GmbH

Memo Therapeutics AG

Merck KGaA, Darmstadt, Germany

Metys Pharmaceuticals AG

Mewburn Ellis LLP

Mirabaud & Cie SA

Modi VC

Monte Rosa Therapeutics, Inc.

Montis Biosciences BV

Move Venture Consulting

Naissance Capital

Nanoligent SL

NatIgGs GmbH

Nerai Bioscience

Nestler Life Sciences Advisory

NETRIS Pharma

Neurimmune AG

NEUWERK Partnerschaft von

New Science Fund

Nextech

Nimvec Therapeutics BV

NLC Health Ventures

NodThera, Inc.

Nomal Therapeutics

Novalix SAS

Novartis Pharma AG

Novartis Venture Fund

Novateur Ventures Inc

Novo Holdings A/S

NRW.Venture

NRx Pharmaceuticals, Inc.

Nucleate Switzerland

Nuclidium

O11 Biomedical GmbH

Ochre Bio Ltd.

OncoNex-Remunity Therapeutics SAS

Ontario Brain Institute

OPIS s.r.l.

Optigo Biotherapeutics Inc.

OrbiMed

Oxford Science Enterprises

palleos healthcare GmbH

Panakès Partners SGR SpA

Paris Saclay Cancer Cluster (PSCC)

Phialogics AG

PhoreMost Ltd.

PIAM Farmaceutici S.P.A.

Point6 Bio

Power Station Capital Ltd

Procavea Biotech AG

Pureos Bioventures

QUANTRO Therapeutics GmbH

QureTech Oncology

Recordati Pharma GmbH

Redalpine Venture Partners AG

Rejuvenate Biomed NV

Resolution Therapeutics

RIANA Therapeutics GmbH

Roche Venture Fund

Roy Consulting

RV Invest GmbH

Ryvu Therapeutics S.A.

Sanavia Oncology

Sappiens SAS

Schroders Capital

SCI Ventures LLC

Scienion GmbH

SciRhom GmbH

Secarna Pharmaceuticals GmbH & Co. KG

Seekyo Therapeutics

Selvita S.A.

SEQENS

Serenatis Bio

Seroba Life Sciences

Serpentine Ventures

Seventure Partners

SICTIC

Solgate GmbH

Sphene Capital GmbH

Staatz BD & Strategy

StemSight Oy

Sterne, Kessler, Goldstein & Fox PLLC

Stifel

Strike Pharma AB

SUPERBRANCHE

Swiss Biotech Association

Switchkine SA

Synendos Therapeutics AG

Taiho Ventures, LLC

Tanai Therapeutics

Tandem Therapeutics AG

TargImmune Therapeutics AG

TAXIS Pharmaceuticals, Inc.

The Fulford Group Ltd.

TheraPPI Bioscience SA

TheraVenture GmbH

Tigermed

TILT Biotherapeutics Ltd.

TOLREMO therapeutics AG

Torrey Pines Investment

TransCure bioServices SAS

Treamid Therapeutics GmbH

Tribune Therapeutics AB

Tridek-One Therapeutics

Tuari Therapeutics GmbH

UCEA Family Office

Ultimate Medicine AG

Umlaut.bio GmbH

UMZH Translational Medicine Accelerator

University of Zurich

VALANX Biotech GmbH

Valor Management

Vandria SA

Vectiopep

Veeva Systems Inc.

Venture Valuation

Versant Ventures

Verve Ventures

Vesna Deeptech VC

VI Partners AG

Viopas Venture Consulting GmbH

Vitarka Therapeutics Ltd

Vogel BioC

VSP Investments

Weatherden Ltd

Wellington Partners

Worldwide Clinical Trials

XGEN Venture SGR S.p.A.

XOventure GmbH

Y-king Biologics

YAYA Capital

Ysios Capital

Zinc VC